BioStem Technologies, Inc. (BSEM)
Makes tissue grafts from placental material to heal wounds and damaged tissue.
$3.40-0.11%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-69.8%
The outlook
BSEM trades at $3.40, well below both its 50- and 200-day moving averages and near its 52-week low. Analyst coverage shows an average price target around 106% above the current price, though the overall sentiment leans bearish. The stock's trailing P/E of 4.4 reflects a deeply depressed valuation.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range3% of the way from its 52-week low to high
Price targetAvg target +106% vs current price
Market cap
$57.7M
52-wk high
$12.00
52-wk low
$3.09
50-day avg
$3.81
200-day avg
$4.59
Trailing P/E
4.4